Kevin Rodondi, PharmD
Professor Emeritus
Clinical Pharmacy
School of Pharmacy
Kevin Rodondi, Pharm.D. is Clinical Professor Emeritus of Pharmacy at the University of California San Francisco (UCSF) where he taught entrepreneurship and leadership in the School of Pharmacy and was the Associate Director of Leadership at the Healthforce Center.
Show full bio (160 words) Hide full bio
He was a national instructor for the NSF I-Corps Program, Domain Expert in Therapeutics for the NIH I-Corps Program and helped launch the first cohort of the NSF Convergence Accelerator as the Head Coach. Prior to the joining the faculty at UCSF he was a serial entrepreneur in healthcare and a member of the founding management team or co-founder of multiple companies including Access Biotechnology, the Oncology Therapeutics Network, and the National Oncology Alliance. He has mentored hundreds of early-stage entrepreneurs with STEM technologies in multiple disciplines nationally and continues to do so. He currently volunteers as a mentor with the growing innovation ecosystem in Hawaii including the HITIDE program at the University of Hawaii at Manoa and the Hawaii Technology Development Corporation (HTDC). Dr. Rodondi received a B.A. in physiology and chemistry from San Francisco State University, his Pharm.D. from UCSF, and completed two years of post-doctoral residency at UCSF.
Education & Training
Show all (2) Hide
- PHA Primary Practice Residency Pharmacy University of California, San Francisco 1986
- Pharm.D. Pharmacy University of California, San Francisco 1985
Websites
Show all (5) Hide
- Healthforce Center at UCSF (healthforce.ucsf.edu)
- HITIDE (hitide.research.hawaii.edu)
- Posts on X kevinrodondi (X.com)
- NSF Convergence Accelerator (beta.nsf.gov)
- NIH I-Corp (sbir.cancer.gov)
Publications (3)
Top publication keywords:
DoxorubicinCost-Benefit AnalysisAcademic Medical CentersMedical OncologyQualitative ResearchReproducibility of ResultsDrug-Related Side Effects and Adverse ReactionsDrug PackagingFocus GroupsPatient-Centered CareDrug LabelingPharmacistsDrug CostsAntineoplastic AgentsNeoplasms
-
What Is a Medication-Related Problem? A Qualitative Study of Older Adults and Primary Care Clinicians.
Journal of general internal medicine 2019 Nicosia FM, Spar MJ, Stebbins M, Sudore RL, Ritchie CS, Lee KP, Rodondi K, Steinman MA -
Evaluation of the ASCO Value Framework for Anticancer Drugs at an Academic Medical Center.
Journal of managed care & specialty pharmacy 2017 Wilson L, Lin T, Wang L, Patel T, Tran D, Kim S, Dacey K, Yuen C, Kroon L, Brodowy B, Rodondi K -
Doxorubicin multiple-dose vials.
American journal of hospital pharmacy 1990 Rodondi KM